MaxCyte Inc - cell-engineering technology platform based in US state of Maryland - Non-Executive Chair Richard Douglas buys 80,000 shares at average $4.32, worth $345,480, on Wednesday. Now has 100,000 shares, a 0.1% stake. Current stock price: 367.05 pence, up 7.2% in London on Thursday 12-month change: down 34% Copyright 2023 Alliance News Ltd. All Rights Reserved.
|